Filing Flows › Twist Bioscience (TWST) › R&D spending
Twist Bioscience (TWST) R&D spending by quarter
Twist Bioscience's R&D spending was $18.0M in Q3 FY26 (third quarter fiscal 2026), -8% from Q2 FY26. Over the last 7 quarters it ranged from $17.0M (Q4 FY25) to $23.9M (Q2 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 FY26 | $18.0M | -8% | -0.1% |
| Q2 FY26 | $19.7M | +15% | -18% |
| Q1 FY26 | $17.1M | +0.7% | — |
| Q4 FY25 | $17.0M | -6% | -19% |
| Q3 FY25 | $18.0M | -25% | — |
| Q2 FY25 | $23.9M | +13% | — |
| Q4 FY24 | $21.1M | — | — |
Q3 FY26 at a glance
Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Twist Bioscience's R&D spending?
Twist Bioscience's R&D spending was $18.0M in Q3 FY26 (third quarter fiscal 2026), -8% from Q2 FY26.
How has Twist Bioscience's R&D spending changed?
Over the last 7 quarters it ranged from $17.0M (Q4 FY25) to $23.9M (Q2 FY25).